Suchergebnisse - "Diamond, Benjamin"

PubPharm (20)

1

Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma

enthalten in: Nature communications | 2023

von Coffey, D. | Maura, F. | Gonzalez-Kozlova, E. | +20

2

Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures

enthalten in: Blood | 2023

von Diamond, B. | Ziccheddu, B. | Maclachlan, K. | +30

CommentIn: Blood. 2023 May 11;141(19):2292-2293. - PMID 37166926

3

Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms

enthalten in: Leukemia research | 2023

von Jahn, J. | Diamond, B. | Hsu, J. | +5

4

Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Shah, U. | Maclachlan, K. | Derkach, A. | +35

5

Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions

enthalten in: Seminars in oncology | 2022

von Chojnacka, M. | Diamond, B. | Landgren, O. | +1

6

Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length

enthalten in: Leukemia | 2022

von Boyle, E. | Williams, L. | Blaney, P. | +24

7

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

enthalten in: Nature communications | 2021

von Maclachlan, K. | Rustad, E. | Derkach, A. | +14

8

The mutagenic impact of melphalan in multiple myeloma

enthalten in: Leukemia | 2021

von Maura, F. | Weinhold, N. | Diamond, B. | +4

9

Travelling waves reveal a dynamic seizure source in human focal epilepsy

enthalten in: Brain : a journal of neurology | 2021

von Diamond, J. | Diamond, B. | Trotta, M. | +3

10

Tailored treatment to MRD response : A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2 ) in combination with lenalidomide and dexamethasone

enthalten in: American journal of hematology | 2021

von Korde, N. | Mastey, D. | Tavitian, E. | +25